Abstract:The membrane glycoprotein CD4 enhances antigen-mediated activation of T cells restricted by class II molecules of the major histocompatibility complex (MHC). This positive function has been attributed to the protein tyrosine kinase p56lck (ref. 4), which is noncovalently associated with the cytoplasmic portion of CD4, and is activated on CD4 aggregation. Antigen presentation by MHC class II molecules coaggregates CD4 and the T-cell antigen receptor (TCR alpha beta-CD3). Thus, the mutual specificity of CD4 and … Show more
“…On the other hand, the role of p56 ~k after stimulation with 46-61WW cannot be fully determined. Although it is clear that PLC'y1 phosphorylation can occur in the absence of the CD4 cytoplasmic tail, these data cannot rule out the involvement of p56 ~k as several studies have shown that it does not have to be associated with CD4 to exert its effect (42,43).…”
Section: Differential Signaling: Tcr Ligatio In the Absence Of Il-2 mentioning
confidence: 68%
“…However, p56 ~k has also been shown to perform important kinase-independent functions during T cell activation (37). Although previous studies have suggested that neither effective T call stimulation nor CD4-TCR association can occur when CD4 cannot associate with p56 ~k (38)(39)(40)(41), recent studies have implied an opposing view with p56 kk playing a critical role in TCR-mediated fignaling and T cell development in vivo in the absence of coupling to CD4 (42)(43)(44).…”
StlmmaryHen egg lysozyme 52-61-specific CD4 + T cells responded by interleukin 2 (IL-2) secretion to any peptide containing this epitope regardless of length of NH2-and COOH-terminal composition. However, CD4-variants could only respond to peptides containing the two COOHterminal tryptophans at positions 62 and 63. Substitutions at these positions defined patterns of reactivity that were specific for individual T cells inferring a T cell receptor (TCR)-based phenomenon. Thus, the fine specificity of major histocompatibility complex (MHC)-peptide recognition by the TCR was dramatically affected by CD4 and the COOH-terminal peptide composition. Peptides that failed to induce IL-2 secretion in the CD4-variants nevertheless induced strong tyrosine phosphorylation of CD3~'. Thus, whereas the TCR still recognized and bound to the MHC class II-peptide complex resulting in protein phosphorylation, this interaction failed to induce effective signal transduction manifested by IL-2 secretion. This provides a dear example of differential signaling mediated by peptides known to be naturally processed. In addition, the external domains of CD4, rather than its cytoplasmic tail, were critical in aiding TCK recognition of all peptides derived from a single epitope. These data suggest that the nested flanking residues, which are present on MHC class II but not class I bound peptides, are functionally relevant.
“…On the other hand, the role of p56 ~k after stimulation with 46-61WW cannot be fully determined. Although it is clear that PLC'y1 phosphorylation can occur in the absence of the CD4 cytoplasmic tail, these data cannot rule out the involvement of p56 ~k as several studies have shown that it does not have to be associated with CD4 to exert its effect (42,43).…”
Section: Differential Signaling: Tcr Ligatio In the Absence Of Il-2 mentioning
confidence: 68%
“…However, p56 ~k has also been shown to perform important kinase-independent functions during T cell activation (37). Although previous studies have suggested that neither effective T call stimulation nor CD4-TCR association can occur when CD4 cannot associate with p56 ~k (38)(39)(40)(41), recent studies have implied an opposing view with p56 kk playing a critical role in TCR-mediated fignaling and T cell development in vivo in the absence of coupling to CD4 (42)(43)(44).…”
StlmmaryHen egg lysozyme 52-61-specific CD4 + T cells responded by interleukin 2 (IL-2) secretion to any peptide containing this epitope regardless of length of NH2-and COOH-terminal composition. However, CD4-variants could only respond to peptides containing the two COOHterminal tryptophans at positions 62 and 63. Substitutions at these positions defined patterns of reactivity that were specific for individual T cells inferring a T cell receptor (TCR)-based phenomenon. Thus, the fine specificity of major histocompatibility complex (MHC)-peptide recognition by the TCR was dramatically affected by CD4 and the COOH-terminal peptide composition. Peptides that failed to induce IL-2 secretion in the CD4-variants nevertheless induced strong tyrosine phosphorylation of CD3~'. Thus, whereas the TCR still recognized and bound to the MHC class II-peptide complex resulting in protein phosphorylation, this interaction failed to induce effective signal transduction manifested by IL-2 secretion. This provides a dear example of differential signaling mediated by peptides known to be naturally processed. In addition, the external domains of CD4, rather than its cytoplasmic tail, were critical in aiding TCK recognition of all peptides derived from a single epitope. These data suggest that the nested flanking residues, which are present on MHC class II but not class I bound peptides, are functionally relevant.
“…CD4 can enhance the T cell response regardless of whether it binds to the same or to different MHC molecules as the TCR (2). The engagement of CD4 with ligand or anti-CD4 in solution can positively or negatively affect the outcome of TCR/CD3 stimulation, which appears to be dependent on the concentration of anti-CD4 Ab and the conditions used for costimulation of CD4 (57)(58)(59)(60)(61)(62). The inhibition of CD3/TCR signaling was also observed by cross-linking of CD4 incapable of Lck binding (equivalent to our 2C CD4) (62).…”
By mutagenesis, we demonstrated that the palmitoylation of the membrane-proximal Cys396 and Cys399of CD4, and the association of CD4 with Lck contribute to the enrichment of CD4 in lipid rafts. Ab cross-linking of CD4 induces an extensive membrane patching on the T cell surface, which is related to lipid raft aggregation. The lipid raft localization of CD4 is critical for CD4 to induce the aggregation of lipid rafts. The localization of CD4 in lipid rafts also correlates to the ability of CD4 to enhance receptor tyrosine phosphorylation. Thus, our data suggest that CD4-induced aggregation of lipid rafts may play an additional role in CD4 signaling besides its adhesion to MHC molecules and association with Lck.
“…First, Lck is involved in ligandinduced TCR internalization and thus may regulate the availability of TCR and the magnitude of T cell signaling (7)(8)(9)(10)(11). Second, separate ligation of TCR and CD4 causes Lck activation and inhibits T cell responses by priming CD4 ϩ T cells for death (12,13).…”
Section: Superantigen Stimulation Reveals the Contribution Of Lck Tomentioning
The conventional paradigm of T cell activation through the TCR states that Lck plays a critical activating role in this signaling process. However, the T cell response to bacterial superantigens does not require Lck. In this study we report that not only is Lck dispensable for T cell activation by superantigens, but it actively inhibits this signaling pathway. Disruption of Lck function, either by repression of Lck gene expression or by selective pharmacologic inhibitors of Lck, led to increased IL-2 production in response to superantigen stimulation. This negative regulatory effect of Lck on superantigen-induced T cell responses required the kinase activity of Lck and correlated with early TCR signaling, but was independent of immunological synapse formation and TCR internalization. Our data demonstrate that the multistage role of Lck in T cell signaling includes the activation of a negative regulatory pathway of T cell activation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.